MSI-1436 has been shown to engage PTP1B as a target in cell and animal models of breast cancer (19) and has been tested in clinical trials for obesity and metastatic breast cancer. This evidence concerns the gene PTPN1 and obesity due to melanocortin 4 receptor deficiency.